Search Results
Sep 26, 2025, 07:35 ET Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
(SBRT) treatments and surface-guided ration therapy (SGRT), to optimize outcomes for standard radiation therapy indications including breast, prostate, lung, and head and neck cancers, in addition to complex treatments such as total marrow irradiation. Accuray Stellar provides a unique option for accurately
More news about: Accuray Incorporated
Sep 25, 2025, 20:47 ET Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth
inhibitor, Glecirasib, was approved by the National Medical Products Administration (NMPA) for second-line monotherapy in KRAS G12C mutant non-small cell lung cancer (NSCLC) and successfully launched in China. This milestone not only marked Jacobio's first commercial entry
More news about: Jacobio Pharma
Sep 25, 2025, 14:01 ET U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
survival estimates.4 About Breast CancerBreast cancer is the second most commonly diagnosed cancer worldwide (following lung cancer), according to GLOBOCAN. The estimated 2.3 million new cases indicate that close to 1 in every 4 cancers diagnosed in 2022 is breast cancer.
More news about: Eli Lilly and Company
Sep 25, 2025, 10:15 ET ELEPHAS BIOSCIENCES WELCOMES DR. JEROME GALON TO THE COMPANY'S EXPANDING SCIENTIFIC ADVISORY BOARD
M.Sc., Pathologist, Melanoma, Johns Hopkins MedicineJacob Sands, M.D., Medical Oncologist, Small Cell Lung Cancer, Dana-Farber Cancer InstituteAlan Venook, M.D., Medical Oncologist, Gastrointestinal Oncology,
More news about: Elephas
Sep 25, 2025, 09:30 ET Israel Cancer Research Fund Partners with The Mark Foundation for Cancer Research to Support Lung Cancer Project Grant at Weizmann Institute of Science
series of bispecific antibodies in animal models that have not yet been evaluated for lung cancer. These innovative, engineered therapies could pave the way for future advances in lung cancer treatment for humans. "Lung cancer remains a devastating disease, and Prof. Yarden's approach to tackling drug
More news about: Israel Cancer Research Fund
Sep 25, 2025, 07:41 ET Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
improve PH patient function and symptoms, including for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). There are no approved PRN therapies for PAH or PH-ILD, and despite existing treatment options, the majority of PH patients continue
More news about: Respira Therapeutics, Inc.
Sep 25, 2025, 07:30 ET Sanolla Launches the World's First Smart AI-powered Stethoscope Offering Full-Spectrum Auscultation
VoqX smart stethoscope, the first AI-powered device capable of analyzing both heart and lung sounds, now directly available to physicians. VoqX is the world's
More news about: Sanolla
Sep 24, 2025, 14:56 ET Maen Hussein, MD Meets With King Abdullah II Ahead of UN General Assembly to Strengthen U.S.-Jordan Medical Ties
and advocate for the vital importance of clinical trials, Dr. Hussein has served as principal investigator on numerous clinical trials with a focus on lung cancer. His work has been published and presented in prestigious industry publications and symposiums. Dr. Hussein also serves as president of the Florida
More news about: Florida Cancer Specialists & Research Institute
Sep 24, 2025, 10:30 ET In Vitro Diagnostics (IVD) Quality Control Market Poised for Strong Growth Amid Rising Demand for Accurate Diagnostics: Verified Market Research®
Reports: Global In Vitro Lung Model Market Size By Type (2D Models, 3D Models), Application (Drug Screening, Toxicology), By Geography, And Forecast
More news about: Verified Market Research
Sep 24, 2025, 09:02 ET Immorta Bio Reports Preclinical Activity of Senolytic Immunotherapy SenoVax™ in a Chronic Traumatic Encephalopathy (CTE) Model
control across lung, breast, glioma, and pancreatic settings, synergy with checkpoint inhibitors, and immune rejuvenation signals (CD8/NK activity). Immorta Bio has filed an IND to begin clinical evaluation of SenoVax™ in advanced non–small cell lung cancer (NSCLC)
More news about: Immorta Bio, Inc.
Sep 24, 2025, 09:00 ET SciTech Development Announces the Closing of Oversubscribed $5.5 Million Funding Round to Continue Cancer Clinical Trials
Andrew Stumpf, CFO of SciTech Development. "This investment enables us to continue to advance clinical development in both T-cell NHL and Small Cell Lung Cancer, while building a strong foundation for our future pipeline." About SciTech Development, Inc.SciTech Development is a
More news about: SciTech Development, Inc.
Sep 24, 2025, 07:00 ET SystImmune, Inc. to Present New Clinical Data on Izalontamab Brengitecan and BL-M07D1 Highlighting Strength of Differentiated Antibody Drug Conjugate (ADC) Platform
ChinaResults from the first Phase 1 study of iza-bren in a global patient population (BL-B01D1-LUNG-101) with metastatic or unresectable non-small cell lung cancer (NSCLC) and other solid tumorsSafety and efficacy results of iza-bren as a monotherapy in patients
More news about: SystImmune, Inc.
Sep 24, 2025, 06:30 ET Nuvalent to Participate in the UBS 2025 Virtual Oncology Day
responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
More news about: Nuvalent, Inc.
Sep 24, 2025, 06:07 ET People Diagnosed with Lung Cancer Aren't Getting Vital Tests; New Campaign Hopes to Change That
Health. About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Sep 23, 2025, 12:04 ET Cizzle Bio Champions Cancer Survivors, Early Detection as Sponsor of Prevent Cancer Foundation® 40th Anniversary and Gala
23, 2025 /PRNewswire/ -- Cizzle Bio, Inc., a biotechnology company advancing groundbreaking biomarker blood tests for early detection of lung and gastric cancers, proudly sponsored and attended the Prevent Cancer Foundation® 40th Anniversary and Gala on Sept.
More news about: Cizzle Bio
Sep 23, 2025, 10:30 ET Nanoparticle Based Vaccines to Treat, Prevent Severe Allergic Reactions
to be critical in the induction of a variety of allergic responses (e.g. Interleukin-4 and Interleukin-13), less mucus production in the lung, and protection from lung hyper-responsiveness that is typically seen in asthma. The treated mice also produced allergen-specific antibodies known to block allergic
More news about: Cincinnati Children's Hospital Medical Center
Sep 23, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR
"announce[ing] topline results from the Phase 3 EFZO-FIT™ study of efzofitimod in 268 patients with pulmonary sarcoidosis, a major form of interstitial lung disease." The press release disclosed, in relevant part, that the trial had failed to meet its primary endpoint. On this news, aTyr's stock
More news about: Pomerantz LLP
Sep 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
in a Phase 3 IMPALA-2 pivotal clinical trial for the treatment of autoimmune pulmonary alveolar proteinosis ("aPAP"), a chronic and debilitating rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. Savara has consistently represented that, based on investments
More news about: Pomerantz LLP
Sep 23, 2025, 09:30 ET Lung Cancer Research Foundation and Oncology Advocates United for Climate and Health - International Announce New Research Collaboration
expertise and pursuit of solutions for the lung cancer community will help to improve the body of research that informs how lung cancer is detected, diagnosed, and treated." About the Lung Cancer Research Foundation (LCRF) The Lung Cancer Research Foundation® (LCRF)
More news about: Lung Cancer Research Foundation
Sep 23, 2025, 09:22 ET aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman
over 80% after the company reported that its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease ("ILD"), did not meet its main goal.
More news about: Hagens Berman Sobol Shapiro LLP
Sep 23, 2025, 09:00 ET Flint Cooper Cohn Thompson & Miracle Welcomes Veteran Asbestos Litigator Courtney Gregory as Partner
specializing in asbestos litigation. Courtney brings nearly two decades of focused experience representing victims of mesothelioma and asbestos-related lung cancer, significantly strengthening the firm's asbestos litigation practice.
More news about: Flint Cooper
Sep 23, 2025, 08:36 ET CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
made false or misleading statements to investors regarding its Pinnacle Study, a clinical trial involving poziotinib, a drug intended to treat certain lung cancer patients. Spectrum shares were delisted following the Company's merger with Assertio Holdings, Inc. (NASDAQ: ASRT). If you
More news about: Berger Montague
Sep 23, 2025, 08:35 ET HKeyBio Lauched the Most Comprehesive Non-human Primate Autoimmune & Allergic Disease Model Matrix to Redefining Clinical Translation
system development. Primate models, by contrast, offer: Closer anatomical and developmental similarity in key organs (e.g. lung branching, epithelial lineages, immune cell distributions) that are central to respiratory, dermatologic, or gastrointestinal pathologies.Barrier
More news about: HKeyBio
Sep 23, 2025, 08:09 ET Annals of Family Medicine: Two Articles Offer Practical Ways to Make Primary Care Easier for Older Adults
clinician (12.5% vs. 25.4%). Orders and screenings increased across multiple measures such as depression, falls, function, pain; breast/cervical/colorectal/lung cancer screening; DEXA; hemoglobin A1c; urine microalbumin; hepatitis C; and HIV. In an
More news about: Annals of Family Medicine
Sep 23, 2025, 06:30 ET "Ultimate H2 is KEY to my Recovery," says Triathlete. Power Your Workouts with the Molecular Energy Booster: Gundry MD Ultimate H2
Steven Gundry was one of the world's top cardiothoracic surgeons Currently, he's the medical director at The International Heart and Lung Institute and The Centers for Restorative Medicine in Palm Springs and Santa Barbara, California
More news about: Gundry MD